key: cord-0308210-9x7f2m3g authors: Clavarino, G.; Leroy, C.; Epaulard, O.; Raskovalova, T.; Vilotitch, A.; Pernollet, M.; Dumestre-Perard, C.; Defendi, F.; Le Marechal, M.; Le Gouellec, A.; Audoin, P.; Bosson, J.-L.; Poignard, P.; Roustit, M.; Jacob, M.-C.; Cesbron, J.-Y. title: Fine analysis of lymphocyte subpopulations in SARS-CoV-2 infected patients: toward a differential profiling of patients with severe outcome date: 2021-09-02 journal: nan DOI: 10.1101/2021.08.31.21262538 sha: 4021747e8d5fe9696a5423a093a2787f59fa2050 doc_id: 308210 cord_uid: 9x7f2m3g COVID-19 is caused by the human pathogen severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and has resulted in widespread morbidity and mortality. CD4+ T cells, CD8+ T cells and neutralizing antibodies all contribute to control SARS-CoV-2 infection. However, heterogeneity is a major factor in disease severity and in immune innate and adaptive responses to SARS-CoV-2. We performed a deep analysis by flow cytometry of lymphocyte populations of 125 hospitalized SARS-CoV-2 infected patients on the day of hospital admission. Five clusters of patients were identified using hierarchical classification on the basis of their immunophenotypic profile, with different mortality outcomes. Some characteristics were observed in all the clusters of patients, such as lymphopenia and an elevated level of effector CD8+CCR7- T cells. However, low levels of T cell activation are associated to a better disease outcome; on the other hand, profound CD8+ T-cell lymphopenia, a high level of CD4+ and CD8+ T-cell activation and a high level of CD8+ T-cell senescence are associated with a higher mortality outcome. Furthermore, a cluster of patient was characterized by high B-cell responses with an extremely high level of plasmablasts. Our study points out the prognostic value of lymphocyte parameters such as T-cell activation and senescence and strengthen the interest in treating the patients early in course of the disease with targeted immunomodulatory therapies based on the type of adaptive response of each patient. COVID-19 is caused by the human pathogen severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and has resulted in widespread morbidity and mortality. CD4 + T cells, CD8 + T cells and neutralizing antibodies all contribute to control SARS-CoV-2 infection. However, heterogeneity is a major factor in disease severity and in immune innate and adaptive responses to SARS-CoV-2. We performed a deep analysis by flow cytometry of lymphocyte populations of 125 hospitalized SARS-CoV-2 infected patients on the day of hospital admission. Five clusters of patients were identified using hierarchical classification on the basis of their immunophenotypic profile, with different mortality outcomes. Some characteristics were observed in all the clusters of patients, such as lymphopenia and an elevated level of effector CD8 + CCR7 -T cells. However, low levels of T cell activation are associated to a better disease outcome; on the other hand, profound CD8 + T-cell lymphopenia, a high level of CD4 + and CD8 + T-cell activation and a high level of CD8 + T-cell senescence are associated with a higher mortality outcome. Furthermore, a cluster of patient was characterized by high B-cell responses with an extremely high level of plasmablasts. Our study points out the prognostic value of lymphocyte parameters such as T-cell activation and senescence and strengthen the interest in treating the patients early in course of the disease with targeted immunomodulatory therapies based on the type of adaptive response of each patient. Coronavirus disease 2019 (COVID-19) is caused by the human pathogen severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and has resulted in widespread morbidity and mortality. The total number of lymphocytes, CD4 + T cells, CD8 + T cells and natural killer cells significantly decreases in COVID-19 patients, with the lowest levels in severe cases [1] ; in particular, a decrease in CD8 + T cells and an increase in plasmablasts in infected patients have been described [2] . COVID-19 severity and duration seem to be dependent on the early evasion of innate immune recognition, especially with defects in type 1 interferon pathways [2] , and the subsequent kinetics of the adaptive immune response [3] . Since severe COVID-19 is associated with high levels of IL-6, sepsis has been used as a prototype of critical illness for the understanding of severe COVID-19 pathogenesis. However, even if a low expression of human leucocyte antigen D related (HLA-DR) on CD14 + monocytes has been described in some patients, this pattern is distinct from the immunoparalysis state reported in bacterial sepsis or severe respiratory failure caused by influenza [4] [5] . CD4 + T cells, CD8 + T cells and neutralizing antibodies all contribute to control SARS-CoV-2 infection. However, heterogeneity is a major factor in disease severity and in immune innate and adaptive responses to SARS-CoV-2. Deep immune profiling of lymphocyte populations has been performed by using high dimensional flow cytometry, leading to the definition of different immunotypes: immunotype 1 characterized by CD4 + T cell activation, exhausted CD8 + T cells, presence of plasmablasts and associated with more severe disease, immunotype 2 characterized by less CD4 + T cell activation, the presence of effector CD8 + subsets and proliferating memory B cells, and immunotype 3 with minimal lymphocyte activation response and negatively associated with disease severity [6] [7] . In another study All rights reserved. No reuse allowed without permission. (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. The copyright holder for this preprint this version posted September 2, 2021. ; https://doi.org/10.1101/2021.08.31.21262538 doi: medRxiv preprint conducted with principal components analysis and hierarchical clustering, a vast array of immunological parameters has been measured, with the description of three distinct phenotypes: a humoral response deficiency phenotype, a hyper-inflammatory phenotype and a complement-dependent phenotype [8] . In the present study, we performed a fine analysis of lymphocyte subsets of SARS-CoV-2 infected hospitalized patients on the day of admission in order to better characterize the adaptive immune response and possibly define patient trajectories with different disease progression courses. Overall 146 patients infected with SARS-CoV-2 were recruited in Grenoble Alpes University Hospital between March and September 2020, either in a retrospective (n=127) or in a prospective (n=19) study. Clinical and biological data were fully available for 125 patients (S1 Fig). The study was performed in accordance with the Declaration of Helsinki, Good Clinical Practice guidelines and CNIL (Commission Nationale de l'Informatique et des Libertés) methodology reference. Patients were informed and non-opposition (BioMarCoViD retrospective study) or written consent (AcNT-COVID-19 prospective study) was obtained, according to French law. Ethical approval for the prospective study was given by the relevant ethics committee (Comité de Protection des Personnes Ile de France II, N°IDRCB: 2020-A00904-35) and registered in clinicaltrial.gov (NCT04596098). Laboratory confirmation for SARS-CoV-2 was defined as a positive result of real-time reverse transcriptase-polymerase chain reaction assay of nasopharyngeal swabs. Follow-up of the patients at days 3, 7 and 13 was carried out, and clinical data, oxygen requirements, intensive care unit (ICU) admission, steroid treatment, and laboratory data were collected for each time point; patients were classified in severity classes on the basis of oxygen All rights reserved. No reuse allowed without permission. (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. The copyright holder for this preprint this version posted September 2, 2021. ; https://doi.org/10.1101/2021.08.31.21262538 doi: medRxiv preprint requirement, ICU admission, limitation of therapeutic effort and mortality (S1 Table) , as in [9] . Peripheral blood samples were collected in EDTA-containing tubes (Becton Dickinson). Cell staining was performed on whole blood samples using a direct immunofluorescence Cytometer performances were checked daily using CS&T IVD beads (BD Biosciences). Flow cytometric monocyte HLA-DR expression analysis was performed as described in S1 File. Hierarchical cluster analysis with the Ward method [10] was used to identify groups of SARS-CoV-2 infected patients on the basis of immunophenotypic profiling; the age of the patients was included in the model (S1 File). All rights reserved. No reuse allowed without permission. (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. The lymphocyte subpopulation analysis performed on the day of hospital admission is summarized in Table 2 ; immunophenotype of cell subsets is detailed in S4 Table. Lymphopenia was observed, with a median value of total lymphocyte count of 0.9 G/L (IQR (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. Total monocytes, % 7 3 1 5 7 10 16 Non-conventional monocytes, % 13 9 1 7 11 18 45 mHLA-DR, AB/C 1 36847 19587 7765 19850 35952 50973 88031 1 Statistical analysis of each cellular subpopulation is reported in S5 Table; the main characteristics of patients in the different clusters are described in Table 3 . Some characteristics were observed in all the clusters, such as lymphopenia, an elevated level of effector CD8 + CCR7 -T cells (with extremely high levels in clusters 4 and 5) and an elevated level of plasmablasts (with extremely high levels in cluster 3). Patients in cluster 1 were the youngest patients (mean age 56), with low T-cell activation (HLA-DR + /CD4 + mean 7 % and HLA-DR + /CD8 + mean 21 %) and very low T-cell senescence (CD57 + /CD4 + mean 2 % and CD57 + /CD8 + mean 14 %); no mortality was observed in this cluster. Patients of cluster 2 exhibited high T-cell activation (HLA-DR + /CD4 + mean 11 % and HLA-DR + /CD8 + mean 34 %) and high level of senescent T CD8 + cells (CD57 + /CD8 + mean 33 %). Cluster 3 was specifically characterized by an extremely elevated level of CD19 + CD38 high plasmablasts (mean 33 %); T-cell activation was very high (HLA-DR + /CD4 + mean 17 %; HLA-DR + /CD8 + mean 49 %), with very low level of senescent T cells (CD57 + /CD4 + mean 2 % and CD57 + /CD8 + mean 18 %). Cluster 4 was characterized by an extremely high level of effector CD8 + CCR7 -T cells (mean 85 %), a very high level of T-cell activation (HLA-DR + /CD4 + mean 16 %; HLA-DR + /CD8 + mean 37 %) and T-cell senescence (CD57 + /CD4 + mean 19 % and CD57 + /CD8 + mean 52 %). Similarly to cluster 4, cluster 5 was characterized by an extremely high level of effector CD8 + CCR7 -T cells (mean 84 %), a very high level of T-cell activation (HLA-DR + /CD4 + mean 14 %; HLA-DR + /CD8 + mean 48 %) and CD8 + T-cell senescence (CD57 + /CD8 + mean 44 %); patients in cluster 5 were the oldest (mean age 79). To All rights reserved. No reuse allowed without permission. (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. The copyright holder for this preprint this version posted September 2, 2021. ; https://doi.org/10.1101/2021.08.31.21262538 doi: medRxiv preprint note, cluster 4 was the only cluster characterized by normal levels of CD8 + cells (mean 0.4 G/L) and a high level of effector CD4 + CCR7 -T cells (mean 39 %) ( Table 3, Fig 1, S6 Table) . Concerning patient characteristics, there was no statistically significant difference among the clusters for sex, BMI, C-Reactive Protein (CRP), classes of severity, O 2 requirement and ICU admission. However, a significant difference was observed concerning mortality, with a higher death rate in clusters 2 and 5 compared with the other clusters (Table 4 ). indicating that patients were mainly in a status of immunocompetence. Immunosuppression status which has been described in some studies [5] has been observed mainly in patients hospitalized in ICU. Overall, exhibiting low levels of T-cell activation seems to be associated to a better disease outcome, as described in [6] ; on the other hand, exhibiting profound CD8 + T-cell lymphopenia, a high level of CD4 + and CD8 + T-cell activation and a high level of CD8 + T-cell senescence seems to be globally associated with a higher mortality outcome. Patients of our study were all hospitalized and recruited between March and September 2020. Therefore, we described here the immunophenotypic subset profiles of only All rights reserved. No reuse allowed without permission. (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. The copyright holder for this preprint this version posted September 2, 2021. ; https://doi.org/10.1101/2021.08.31.21262538 doi: medRxiv preprint severe cases from the first wave. It would be interesting to explore the profiles of not hospitalized patients with mild pathology, and those of patients infected with new circulating SARS-CoV-2 variants. Our study suggests that some lymphocyte parameters might be useful to physicians to better characterize patients at hospital admission; in particular, identification of patients with potential mild (with low levels of T-cell activation) or very serious (with profound CD8 + Tcell lymphopenia, a high level of CD4 + and CD8 + T-cell activation and a high level of CD8 + T-cell senescence) evolution of the pathology could be helpful in order to treat them earlier and more appropriately. In this perspective, specific studies evaluating T-cell activation and senescence in a longitudinal patient follow-up are certainly needed. Characteristics of Peripheral Lymphocyte Subset Alteration in COVID-19 Pneumonia Impaired type I interferon activity and inflammatory responses in severe COVID-19 patients No reuse allowed without permission. (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity Adaptive immunity to SARS-CoV-2 and COVID-19 Complex Immune Dysregulation in COVID-19 Patients with Severe Respiratory Failure Monocyte HLA-DR Measurement by Flow Cytometry in COVID-19 Patients: An Interim Review Comprehensive mapping of immune perturbations associated with severe COVID-19 Identification of Distinct Immunophenotypes in Critically Ill Coronavirus Disease A General Theory of Classificatory Sorting Strategies No reuse allowed without permission. (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity Accumulation of memory T cells from childhood to old age: central and effector memory cells in CD4(+) versus effector memory and terminally differentiated memory Clustering Methods Data Mining and Knowledge Discovery Handbook No reuse allowed without permission. (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity The authors would like to thank Ghislaine Del Vecchio, Richard Di Schiena, Laure Dusset, Claire Gasquez, Frédérique Martinez, Karine Nicolino and Véronique Bergerot who provided technical support and Sylvie Berthier who helped to collect clinical data.